The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions

2020-11-09 12:26:12

Shanthi Rexaline

Mon, November 9, 2020, 1:47 AM GMT+8·10 min read

Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of guard at the White House.

The week witnessed a flurry of earnings from several smid-cap companies. Bluebird bio Inc. (NASDAQ: BLUE) shares came under pressure after it announced a push back in the timeline for the regulatory filing for its gene therapy to treat sickle cell disease.

閱讀全文
  • 相關廠商

    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing


    建誼生技股份有限公司

    Founded and managed by a group of experienced scientists previously working at ScinoPharm Taiwan’s custom synthesis team, KriSan Biotech offers world class services of new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II. KriSan Biotech was formed to provide high quality chemistry process and analytical R&D services with Asian advantages and western know-how. The company occupies 2,700 m² of suites located in Southern Taiwan Science Park, we are proud to provide the following services: • Process and analytical R&D for small molecules and peptides from Pre-clinical to Phase II • CGMP manufacturing of API for clinical trials (few grams to kilograms scale) • Stability test in accordance to ICH guidelines • CMC Preparation for IND Filing